| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adolescent characteristics and incidence of pre-malignant disease and invasive tumors of the cervix
|
Keinan Boker, Lital
|
|
|
30 |
7 |
p. 959-968
|
article
|
| 2 |
African American women with advanced-stage ovarian cancer have worse outcomes regardless of treatment type
|
Whitmore, Gabrielle
|
|
|
30 |
7 |
p. 1018-1025
|
article
|
| 3 |
A guide to poly ADP-ribose polymerase inhibitor (PARPi) toxicity management
|
Patel, Shrina Divyesh
|
|
|
30 |
7 |
p. 916
|
article
|
| 4 |
A seven-step surgical strategy for robotic splenectomy
|
Katebi Kashi, Payam
|
|
|
30 |
7 |
p. 1079-1080
|
article
|
| 5 |
Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 study
|
Klapdor, Rudiger
|
|
|
30 |
7 |
p. 920-926
|
article
|
| 6 |
CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study
|
Mayadev, Jyoti
|
|
|
30 |
7 |
p. 1065-1070
|
article
|
| 7 |
Candidate HPV genotypes not included in the 9-valent vaccine for prevention of CIN 2–3
|
Gonzalez-Bosquet, Eduardo
|
|
|
30 |
7 |
p. 954-958
|
article
|
| 8 |
β-catenin and PD-L1 expression in mismatch repair deficient endometrial carcinomas
|
Rowe, Margaret
|
|
|
30 |
7 |
p. 993-999
|
article
|
| 9 |
Combination of sentinel lymph node mapping and uterine frozen section examination to reduce side-specific lymphadenectomy rate in endometrial cancer: a Turkish Gynecologic Oncology Group study (TRSGO-SLN-002)
|
Altin, Duygu
|
|
|
30 |
7 |
p. 1005-1011
|
article
|
| 10 |
Correction: Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer
|
|
|
|
30 |
7 |
p. 1084
|
article
|
| 11 |
Correction: Impact of sentinel lymph node frozen section evaluation to avoid combined treatment in early-stage cervical cancer
|
|
|
|
30 |
7 |
p. 1087
|
article
|
| 12 |
Correction: Prophylactic human papillomavirus vaccination to prevent recurrence of cervical intraepithelial neoplasia: a meta-analysis
|
|
|
|
30 |
7 |
p. 1085-1086
|
article
|
| 13 |
Expression of immune cell markers and tumor markers in patients with cervical cancer
|
Zhang, Liming
|
|
|
30 |
7 |
p. 969-974
|
article
|
| 14 |
Frontline fighters: the continued fight against COVID-19
|
Akilli, Huseyin
|
|
|
30 |
7 |
p. 1077-1078
|
article
|
| 15 |
Impact of PD-L1 and T-cell inflamed gene expression profile on survival in advanced ovarian cancer
|
Høgdall, Estrid
|
|
|
30 |
7 |
p. 1034-1042
|
article
|
| 16 |
Laparoscopic Boari flap formation in advanced ovarian carcinoma
|
Daly, Niamh
|
|
|
30 |
7 |
p. 1081
|
article
|
| 17 |
Letrozole in the management of advanced ovarian cancer: an old drug as a new targeted therapy
|
Marchetti, Claudia
|
|
|
30 |
7 |
p. 1058-1064
|
article
|
| 18 |
Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events
|
Madariaga, Ainhoa
|
|
|
30 |
7 |
p. 903-915
|
article
|
| 19 |
Molecular and biological profile may discriminate between synchronous or metachronous endometrial and ovarian cancer
|
Iacobelli, Valentina
|
|
|
30 |
7 |
p. 1071-1076
|
article
|
| 20 |
Multidisciplinary personalized approach in the management of vulvar cancer – the Vul.Can Team experience
|
Tagliaferri, Luca
|
|
|
30 |
7 |
p. 932-938
|
article
|
| 21 |
Multimodality adjuvant therapy and survival outcomes in stage I–IV uterine carcinosarcoma
|
McEachron, Jennifer
|
|
|
30 |
7 |
p. 1012-1017
|
article
|
| 22 |
Palliative electrochemotherapy in primary or recurrent vulvar cancer
|
Corrado, Giacomo
|
|
|
30 |
7 |
p. 927-931
|
article
|
| 23 |
Palliative treatment with electrochemotherapy in recurrent or metastatic vaginal cancer
|
Perrone, Anna Myriam
|
|
|
30 |
7 |
p. 939-946
|
article
|
| 24 |
Patient-initiated follow-up for low-risk endometrial cancer: a cost-analysis evaluation
|
Luqman, Iqra
|
|
|
30 |
7 |
p. 1000-1004
|
article
|
| 25 |
Patterns of recurrence after laparoscopic versus open abdominal radical hysterectomy in patients with cervical cancer: a propensity-matched analysis
|
Bogani, Giorgio
|
|
|
30 |
7 |
p. 987-992
|
article
|
| 26 |
Perineal resection and anorectal amputation with perforator flap reconstruction by a dorsal approach in prone Jackknife position
|
Martínez-Gómez, Carlos
|
|
|
30 |
7 |
p. 1082-1083
|
article
|
| 27 |
Post-operative pancreatic fistula following splenectomy with or without distal pancreatectomy at cytoreductive surgery in advanced ovarian cancer
|
Bizzarri, Nicolò
|
|
|
30 |
7 |
p. 1043-1051
|
article
|
| 28 |
Radiologic Assessment of Groin Lymph Nodes in Pelvic Malignancies
|
Rudra, Soumon
|
|
|
30 |
7 |
p. 947-953
|
article
|
| 29 |
Radiotherapy in Southern Italy at the time of COVID-19: options for radiation oncology units
|
Pezzulla, Donato
|
|
|
30 |
7 |
p. 917-919
|
article
|
| 30 |
Real world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly-ADP ribose polymerase inhibitors
|
Lord, Rosemary
|
|
|
30 |
7 |
p. 1026-1033
|
article
|
| 31 |
Simple vaginal trachelectomy in women with early-stage low-risk cervical cancer who wish to preserve fertility: the new standard of care?
|
Plante, Marie
|
|
|
30 |
7 |
p. 981-986
|
article
|
| 32 |
The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy
|
Hwang, Woo Yeon
|
|
|
30 |
7 |
p. 975-980
|
article
|
| 33 |
Use of ablation and ultrasonic aspiration at primary debulking surgery in advanced stage ovarian, fallopian tube, and primary peritoneal cancer
|
Li, Sue
|
|
|
30 |
7 |
p. 1052-1057
|
article
|
Journal description